Novel lead generation of an anti-tuberculosis agent active against non-replicating mycobacteria: exploring hybridization of pyrazinamide with multiple fragments

Whole Cell Screen for Inhibitors of pH Homeostasis in Mycobacterium tuberculosis

(2013) Crystal M. Darby et al.   PLoS One

Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition

(2012) Brian S. Safina et al.   JOURNAL OF MEDICINAL CHEMISTRY

Incorporation of Heterocycles into the Backbone of Peptoids to Generate Diverse Peptoid-Inspired One Bead One Compound Libraries

(2012) Animesh Aditya et al.   ACS Combinatorial Science

Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines as Potent α4β2 Nicotinic Acetylcholine Receptor Ligands

(2011) Marc J. C. Scanio et al.   JOURNAL OF MEDICINAL CHEMISTRY

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

(2010) Neel R Gandhi et al.   LANCET

The Population Dynamics and Control of Tuberculosis

(2010) C. Dye et al.   SCIENCE

Tuberculosis: What We Don't Know Can, and Does, Hurt Us

(2010) D. G. Russell et al.   SCIENCE

Acid-Susceptible Mutants of Mycobacterium tuberculosis Share Hypersusceptibility to Cell Wall and Oxidative Stress and to the Host Environment

(2008) O. H. Vandal et al.   JOURNAL OF BACTERIOLOGY

Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis

(2008) Christopher Dye   NATURE REVIEWS MICROBIOLOGY